Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Leases: 2019-2023

Historic Leases for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $10.3 million.

  • ADC Therapeutics' Leases rose 53.13% to $10.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $10.3 million, marking a year-over-year increase of 53.13%. This contributed to the annual value of $6.9 million for FY2022, which is 96284.70% up from last year.
  • ADC Therapeutics' Leases amounted to $10.3 million in Q3 2023, which was down 6.37% from $11.0 million recorded in Q2 2023.
  • ADC Therapeutics' Leases' 5-year high stood at $11.2 million during Q1 2023, with a 5-year trough of $3,402 in Q3 2020.
  • Over the past 3 years, ADC Therapeutics' median Leases value was $7.5 million (recorded in 2021), while the average stood at $7.5 million.
  • As far as peak fluctuations go, ADC Therapeutics' Leases skyrocketed by 221,534.33% in 2021, and later declined by 24.55% in 2022.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Leases stood at $4,898 in 2019, then reached $3,402 in 2020, then spiked by 221,534.33% to $7,164 in 2021, then skyrocketed by 96,284.70% to $6.9 million in 2022, then surged by 53.13% to $10.3 million in 2023.
  • Its Leases stands at $10.3 million for Q3 2023, versus $11.0 million for Q2 2023 and $11.2 million for Q1 2023.